These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10874453)

  • 1. Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
    Cornely OA; Salzberger B; Bethe U; Seifert H; Fätkenheuer G; Diehl V; Schrappe M
    Antibiot Chemother (1971); 2000; 50():37-46. PubMed ID: 10874453
    [No Abstract]   [Full Text] [Related]  

  • 2. Outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Jürgens H
    Antibiot Chemother (1971); 2000; 50():47-58. PubMed ID: 10874454
    [No Abstract]   [Full Text] [Related]  

  • 3. Interventional once-daily administration of ceftriaxone in leukemia and lymphoma patients with febrile neutropenia.
    Karthaus M; Südhoff T; Egerer G; Fenchel K; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Antibiot Chemother (1971); 2000; 50():26-36. PubMed ID: 10874452
    [No Abstract]   [Full Text] [Related]  

  • 4. Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Kullmann KH; Ritter J; Jürgens H
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):501-4. PubMed ID: 9764553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
    Zubizarreta P; Paganini H
    Med Pediatr Oncol; 2002 Apr; 38(4):292. PubMed ID: 11920803
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
    Petrilli AS; Dantas LS; Campos MC; Tanaka C; Ginani VC; Seber A
    Med Pediatr Oncol; 2000 Feb; 34(2):87-91. PubMed ID: 10657866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
    Marie-Cardine A; Schneider P; Blot N; Tron P; Vannier JP
    Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
    Sebban C; Dussart S; Fuhrmann C; Ghesquieres H; Rodrigues I; Geoffrois L; Devaux Y; Lancry L; Chvetzoff G; Bachelot T; Chelghoum M; Biron P
    Support Care Cancer; 2008 Sep; 16(9):1017-23. PubMed ID: 18197434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients.
    Borbolla JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba E; Alvarado ML; Jiménez RM
    Chemotherapy; 2001; 47(5):381-4. PubMed ID: 11561142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia.
    Karthaus M; Wolf HH; Kämpfe D; Egerer G; Ritter J; Peters G; Südhoff T; Franke A; Heil G; Kullmann KH; Jürgens H
    Chemotherapy; 1998; 44(5):343-54. PubMed ID: 9732151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
    Gorschlüter M; Hahn C; Fixson A; Mey U; Ziske C; Molitor E; Horré R; Sauerbruch T; Marklein G; Schmidt-Wolf IG; Glasmacher A
    Support Care Cancer; 2003 Jun; 11(6):362-70. PubMed ID: 12690546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
    Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
    Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.
    Cornely OA; Bethe U; Salzberger B; Franzen C; Hartmann P; Steinmetz T; Fätkenheuer G; Seifert H; Diehl V; Schrappe M
    Ann Hematol; 2001 Feb; 80(2):103-8. PubMed ID: 11261319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone in febrile neutropenia.
    Karthaus M; Cornely OA
    J Chemother; 2003 Jun; 15(3):211-9. PubMed ID: 12868545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
    Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.
    Cornely OA; Bethe U; Seifert H; Breuer K; Schütt-Gerowitt H; Salzberger B; Schrappe M; Fätkenheuer G
    Ann Hematol; 2002 Jan; 81(1):37-43. PubMed ID: 11807634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
    Minotti V; Gentile G; Bucaneve G; Iori AP; Micozzi A; Cavicchi F; Barbabietola G; Landonio G; Menichetti F; Martino P; Del Favero A
    Support Care Cancer; 1999 May; 7(3):134-9. PubMed ID: 10335931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.